BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 15059650)

  • 1. Soft tissue sarcomas of childhood.
    Meyer WH; Spunt SL
    Cancer Treat Rev; 2004 May; 30(3):269-80. PubMed ID: 15059650
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy for soft tissue sarcomas.
    Mertens WC; Bramwell VH
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):801-15. PubMed ID: 7490242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in chemotherapy for patients with extremity soft tissue sarcoma.
    Eilber FC; Tap WD; Nelson SD; Eckardt JJ; Eilber FR
    Orthop Clin North Am; 2006 Jan; 37(1):15-22. PubMed ID: 16311108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of soft tissue sarcomas in 1118 cases.
    Fang ZW; Chen J; Teng S; Chen Y; Xue RF
    Chin Med J (Engl); 2009 Jan; 122(1):51-3. PubMed ID: 19187617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Principles of staging of soft-tissue sarcomas.
    Peabody TD; Simon MA
    Clin Orthop Relat Res; 1993 Apr; (289):19-31. PubMed ID: 8472413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors.
    Carli M; Colombatti R; Oberlin O; Bisogno G; Treuner J; Koscielniak E; Tridello G; Garaventa A; Pinkerton R; Stevens M
    J Clin Oncol; 2004 Dec; 22(23):4787-94. PubMed ID: 15570080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adjuvant chemotherapy in soft tissue sarcoma: review and meta-analysis of published data of randomized clinical trials].
    Budach V
    Strahlenther Onkol; 1996 Jul; 172(7):403-4. PubMed ID: 8693407
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of adjuvant chemotherapy in children and adolescents with surgically resected, high-risk adult-type soft tissue sarcomas.
    Ferrari A; Brecht IB; Koscielniak E; Casanova M; Scagnellato A; Bisogno G; Alaggio R; Cecchetto G; Catania S; Meazza C; Int-Veen C; Kirsch S; Dantonello T; Carli M; Treuner J
    Pediatr Blood Cancer; 2005 Aug; 45(2):128-34. PubMed ID: 15852434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group.
    Bisogno G; Sotti G; Nowicki Y; Ferrari A; Garaventa A; Zanetti I; Favre C; Schiavetti A; Tamaro P; Carli M
    Cancer; 2004 Apr; 100(8):1758-65. PubMed ID: 15073867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?
    Schuetze SM; Patel S
    Oncologist; 2009 Oct; 14(10):1003-12. PubMed ID: 19808770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of prognostic factors in rhabdomyosarcoma. Preliminary univariate and multivariate results of the Cooperative Soft Tissue Sarcoma Study (CWS-81)].
    Suder J; Stienen U; Kaatsch P; Harms D; Schmidt D; Spaar HJ; Treuner J
    Klin Padiatr; 1986; 198(3):218-23. PubMed ID: 3523027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adjuvant chemotherapy for soft tissue sarcoma? a clear no - well - yes-ish].
    Abendroth A; Bauer S
    Dtsch Med Wochenschr; 2013 Oct; 138(41):2107-10. PubMed ID: 24085368
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence and outcomes of extremity soft-tissue sarcomas in children.
    Cheung MC; Zhuge Y; Yang R; Ogilvie MP; Koniaris LG; Rodríguez MM; Sola JE
    J Surg Res; 2010 Oct; 163(2):282-9. PubMed ID: 20638678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: chemotherapy-associated outcomes.
    Cormier JN; Huang X; Xing Y; Thall PF; Wang X; Benjamin RS; Pollock RE; Antonescu CR; Maki RG; Brennan MF; Pisters PW
    J Clin Oncol; 2004 Nov; 22(22):4567-74. PubMed ID: 15542808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early outcomes of soft tissue sarcomas presenting with metastases and treated with chemotherapy.
    King JJ; Fayssoux RS; Lackman RD; Ogilvie CM
    Am J Clin Oncol; 2009 Jun; 32(3):308-13. PubMed ID: 19433963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group.
    Spunt SL; Smith LM; Ruymann FB; Qualman SJ; Donaldson SS; Rodeberg DA; Anderson JR; Crist WM; Link MP
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6072-9. PubMed ID: 15447992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy in localized soft tissue sarcomas: still not proven.
    Blay JY; Le Cesne A
    Oncologist; 2009 Oct; 14(10):1013-20. PubMed ID: 19808771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patients.
    Karavasilis V; Seddon BM; Ashley S; Al-Muderis O; Fisher C; Judson I
    Cancer; 2008 Apr; 112(7):1585-91. PubMed ID: 18278813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Adjuvant chemotherapy in the treatment of sarcomas].
    Fayette J; Blay JY
    Bull Cancer; 2006 Mar; 93(3):257-61. PubMed ID: 16567312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer of the nasal cavity in the pediatric population.
    Benoit MM; Bhattacharyya N; Faquin W; Cunningham M
    Pediatrics; 2008 Jan; 121(1):e141-5. PubMed ID: 18086819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.